£157k
+6%vs Apr 2024Active14173564Private limited companyCambridge
AMICUS CLINICAL DEVELOPMENT LIMITED
Significant control: Gabriel Max Fox (25–50%), Joanna Louise Walker (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Amicus Clinical Development Limited sell?
Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AMICUS CLINICAL DEVELOPMENT LIMITED is an active private limited company (company number 14173564) incorporated on 15 June 2022, registered in Cambridge. Its registered activity is other human health activities (SIC 86900). Latest small accounts cover the period ending 30 April 2025, showing net assets of £157k and cash of £124k, with 2 employees on average. Net assets rose 6% on the prior period (£148k).
Peer position · net assets
By net assets it sits in the top quarter of 309 comparable companies in Cambridge (median £1,849, upper quartile £20k).
02
Ownership and control
- Dr Gabriel Max Fox
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mrs Joanna Louise Walker
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 15 June 20224 yrs ago
- Next accounts due
- 30 January 2027in 99 days
- Confirmation statement due
- 29 June 2027in 249 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£124k
−29%vs Apr 2024Not reported
2
No changevs Apr 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £157k | £124k | — | £325k | — | — | 2 |
| 30 April 2024 | £148k | £174k | — | £90k | — | — | 2 |
Current ratio1.48Current assets ÷ creditors within one year
Cash per employee£62kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £156,973 at 30 April 2025
- Cash at bank of £50,000 or moreCash £124,079
- Incorporated two to five years agoIncorporated 15 June 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 249 days
- Next accounts duein 99 days
- Accounts period endNet assets £157k · small accounts
- Accounts period endNet assets £148k · small accounts
- Incorporated
08
Similar companies in Cambridge
- JBH PRIVATE LIMITEDHaverhill · inc. Jun 2022
- JC OPTICAL LTDCambridge · inc. Jun 2022
- MD CROSS LTDCambridge · inc. Jun 2022
- QUANTUM HEALTH ANALYTICS (UK) LTDCambridge · inc. May 2022
- PAEDIATRIC NEUROLOGY CHAMBERS LIMITEDGreat Chesterford · inc. May 2022
- KM MILLER LTDCambridge · inc. May 2022
All companies incorporated on 15 June 2022 · in Jun 2022.
09
Reminders for AMICUS CLINICAL DEVELOPMENT LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.